We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Comen Medical

Download Mobile App

Follow-Up Research Provides Key Insights into COVID-19 Vaccine Efficacy

Large-scale follow-up studies conducted on those vaccinated by the Pfizer-BioNTech COVID-19 vaccine shed new light on how long antibodies last, effects on types of patients, and effectiveness against the Delta variant. More...
03 Aug 2021
Image: Baricitinib (Photo courtesy of Eli Lilly and Company)

Eli Lilly and Incyte’s Baricitinib Receives FDA EUA for Use as Monotherapy in Hospitalized COVID-19 Patients Requiring Oxygen

The US Food and Drug Administration (FDA) has broadened the emergency use authorization (EUA) for baricitinib, a JAK1/JAK2 inhibitor licensed to Eli Lilly and Company (Indianapolis, Ind, USA) from Incyte (Wilmington, DE, USA), to allow for treatment with or without Gilead Sciences’ (Foster City, CA, USA) antiviral drug remdesivir. More...
30 Jul 2021

Vaccinated Individuals with Lower Level of Antibodies Face Higher Risk of COVID-19 Breakthrough Infections, Finds New Research

Vaccinated individuals with lower level of antibodies are more exposed to COVID-19 breakthrough infections, according to a new study. This could help decide who should be chosen first for the third shot of the COVID-19 vaccine. More...
29 Jul 2021
Image: COVID Risk Calculator (Photo courtesy of Deep Longevity Limited)

AI COVID-19 Survival Calculator Provides Patient's Risk Score, Expected Time to Death and Survival Probability

A new artificial intelligence (AI) tool can estimate the expected time-to-death of hospitalized COVID-19 patients. More...
28 Jul 2021
Image: ExoFlo (Photo courtesy of Direct Biologics, LLC)

Innovative Life-Saving Therapy with Remarkable Healing Properties Could Fulfill Urgent Medical Need in COVID-19 Treatment

An innovative life-saving therapy that leverages the anti-inflammatory and regenerative effects of bone-marrow derived mesenchymal stem cells has demonstrated remarkable healing properties when used on most seriously ill COVID-19 patients. More...
23 Jul 2021

Cardiovascular Test Results Can Identify COVID-19 Patients at Higher Risk of Death During Hospitalization

New research has identified cardiovascular test results that might help to identify patients hospitalized with COVID-19 who face an especially high risk of dying. More...
22 Jul 2021

CRISPR Breakthrough That Blocks SARS-CoV-2 Virus Replication Could Pave Way for New COVID-19 Treatment

Scientists have found a way to stop the SARS-CoV-2 virus from replicating in infected human cells, in a major step towards a new treatment for this and future pandemic viruses. More...
20 Jul 2021
Copyright © 2000-2021 Globetech Media. All rights reserved.